Connection
Gregory Schwartz to CD40 Ligand
This is a "connection" page, showing publications Gregory Schwartz has written about CD40 Ligand.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.059 |
|
|
|
-
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 Jul 27; 110(4):386-91.
Score: 0.059